NEW YORK (Reuters) - Johnson & Johnson and a unit of Imerys SA must pay $117 million in damages to a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.
Original Article: Johnson & Johnson, Imerys must pay $117 million to New Jersey man in asbestos cancer case